The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry
Open accessAbstract
Clinical laboratory testing for HER2 status in breast cancer tissues is critically important for therapeutic decision making. Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) is a powerful tool for investigating proteins through the direct and morphology-driven analysis of tissue sections. We hypothesized that MALDI-IMS may determine HER2 status directly from breast cancer tissues. Breast cancer tissues (n = 48) predefined for HER2 status were subjected to MALDI-IMS, and protein profiles were obtained through direct analysis of tissue sections. Protein identification was performed by tissue microextraction and fractionation followed by top-down tandem mass spectrometry. A discovery and an independent validation set were used to predict HER2 status by applying proteomic classification algorithms. We found that specific protein/peptide expression changes strongly correlated with the HER2 overexpression. Among these, we identified m/z 8404 as cysteine-rich intestinal protein 1. The proteomic signature was able to accurately define HER2-positive from HER2-negative tissues, achieving high values for sensitivity of 83%, for specificity of 92%, and an overall accuracy of 89%. Our results underscore the potential of MALDI-IMS proteomic algorithms for morphology-driven tissue diagnostics such as HER2 testing and show that MALDI-IMS can reveal biologically significant molecular details from tissues which are not limited to traditional high-abundance proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Ross, J. S., Slodkowska, E. A., Symmans, W. F., Pusztai, L., Ravdin, P. M., & Hortobagyi, G. N. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0230 · Cited by 1,144
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems
Cornett, D. S., Reyzer, M. L., Chaurand, P., & Caprioli, R. M. (2007) · Nature Methods · doi:10.1038/nmeth1094 · Cited by 886
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Villanueva, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26022 · Cited by 741
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P., Larsen, P. H., White, B. C., Roberts, J. R., Edgerton, M., Gonzalez, A., Nadaf, S., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14068-8 · Cited by 602
Groseclose, M. R., Massion, P. P., Chaurand, P., & Caprioli, R. M. (2008) · PROTEOMICS · doi:10.1002/pmic.200800495 · Cited by 319
Deininger, S.-O., Ebert, M. P., Fütterer, A., Gerhard, M., & Röcken, C. (2008) · Journal of Proteome Research · doi:10.1021/pr8005777 · Cited by 266
Self-citationProteomics in Diagnostic Pathology
Chaurand, P., Sanders, M. E., Jensen, R. A., & Caprioli, R. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63367-6 · Cited by 253
Schwartz, S. A., Weil, R. J., Thompson, R. C., Shyr, Y., Moore, J. H., Toms, S. A., Johnson, M. D., & Caprioli, R. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3016 · Cited by 235
Terris, B., Blaveri, E., Crnogorac-Jurcevic, T., Jones, M., Missiaglia, E., Ruszniewski, P., Sauvanet, A., & Lemoine, N. R. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61121-2 · Cited by 225
Lemaire, R., Ait Menguellet, S., Stauber, J., Marchaudon, V., Lucot, J.-P., Collinet, P., Farine, M.-O., Vinatier, D., Day, R., Ducoroy, P., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr0702722 · Cited by 196
Cazares, L. H., Troyer, D., Mendrinos, S., Lance, R. A., Nyalwidhe, J. O., Beydoun, H. A., Clements, M. A., Drake, R. R., & Semmes, O. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2892 · Cited by 194
Cornett, D. S., Mobley, J. A., Dias, E. C., Andersson, M., Arteaga, C. L., Sanders, M. E., & Caprioli, R. M. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600119-mcp200 · Cited by 191
Targeting the function of the HER2 oncogene in human cancer therapeutics
Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210478 · Cited by 190
MALDI Imaging Mass Spectrometry
Franck, J., Arafah, K., Elayed, M., Bonnel, D., Vergara, D., Jacquet, A., Vinatier, D., Wisztorski, M., Day, R., Fournier, I., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800016-mcp200 · Cited by 180
Identifying prostate carcinoma by MALDI-Imaging
Schwamborn, K., Krieg, R., Reska, M., Jakse, G., Knuechel, R., & Wellmann, A. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.2.155 · Cited by 168
Missiaglia, E., Blaveri, E., Terris, B., Wang, Y., Costello, E., Neoptolemos, J. P., Crnogorac‐Jurcevic, T., & Lemoine, N. R. (2004) · International Journal of Cancer · doi:10.1002/ijc.20376 · Cited by 164
Mackay, A., Jones, C., Dexter, T., Silva, R. L. A., Bulmer, K., Jones, A., Simpson, P., Harris, R. A., Jat, P. S., Neville, A. M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206349 · Cited by 163
Reyzer, M. L., Caldwell, R. L., Dugger, T. C., Forbes, J. T., Ritter, C. A., Guix, M., Arteaga, C. L., & Caprioli, R. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2231 · Cited by 154
Concise Representation of Mass Spectrometry Images by Probabilistic Latent Semantic Analysis
Hanselmann, M., Kirchner, M., Renard, B. Y., Amstalden, E. R., Glunde, K., Heeren, R. M. A., & Hamprecht, F. A. (2008) · Analytical Chemistry · doi:10.1021/ac801303x · Cited by 121
Wilson, K. S., Roberts, H., Leek, R., Harris, A. L., & Geradts, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64394-5 · Cited by 107
Annecke, K., Schmitt, M., Euler, U., et al. (2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(07)00002-9 · Cited by 105
Self-citationToward Digital Staining using Imaging Mass Spectrometry and Random Forests
Hanselmann, M., Köthe, U., Kirchner, M., Renard, B. Y., Amstalden, E. R., Glunde, K., Heeren, R. M. A., & Hamprecht, F. A. (2009) · Journal of Proteome Research · doi:10.1021/pr900253y · Cited by 97
Systematic Review of HER2 Breast Cancer Testing
Cuadros, M., & Villegas, R. (2008) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e318169fc1c · Cited by 84
Hojilla, C. V., Wood, G. A., & Khokha, R. (2008) · Breast Cancer Research · doi:10.1186/bcr1980 · Cited by 74
Endocrine therapy for breast cancer: an overview
Cheung, K. (2007) · The Breast · doi:10.1016/j.breast.2007.03.004 · Cited by 71
Chivukula, M., Bhargava, R., Brufsky, A., Surti, U., & Dabbs, D. J. (2008) · Modern Pathology · doi:10.1038/modpathol.3801021 · Cited by 52
Hartmer, R., Kaplan, D. A., Gebhardt, C., Ledertheil, T., & Brekenfeld, A. (2008) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2008.05.002 · Cited by 42
Self-citationLiu, S., Stromberg, A. J., Tai, H., & Moscow, J. A. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.477.2.8 · Cited by 37
Tsui, S. K., Yam, N. Y. H., Lee, C. Y., & Waye, M. M. Y. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2693 · Cited by 29
Cited by
Norris, J. L., & Caprioli, R. M. (2013) · Chemical Reviews · doi:10.1021/cr3004295 · Cited by 696
Mass spectrometry imaging with high resolution in mass and space
Römpp, A., & Spengler, B. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1097-6 · Cited by 358
Top‐down proteomics in health and disease: Challenges and opportunities
Gregorich, Z. R., & Ge, Y. (2014) · PROTEOMICS · doi:10.1002/pmic.201300432 · Cited by 217
MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives
Seeley, E. H., & Caprioli, R. M. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.12.002 · Cited by 197
Metadata
- Authors
- Rauser, S., Marquardt, C., Balluff, B., Deininger, S.-O., Albers, C., Belau, E., Hartmer, R., Suckau, D., Specht, K., Ebert, M. P., Schmitt, M., Aubele, M., Höfler, H., & Walch, A.
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-03-05
- Volume
- 9
- Issue
- 4
- Pages
- 1854-1863
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2057888153
- Cited by
- 276
- References
- 33
- FWCI
- 16.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.